# OnCo record quetzal-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/quetzal-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "quetzal-therapeutics" ;
  schema:name "Quetzal Therapeutics"@en ;
  schema:description "Quetzal Therapeutics is developing an arsenic trioxide capsule for acute promyelocytic leukaemia, so that patients could take treatment by mouth instead of spending hours on a drip in hospital."@en ;
  schema:url <https://onco.cc/companies/quetzal-therapeutics/>, <https://quetzaltx.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://quetzaltx.com/>, <https://quetzaltx.com/press/quetzal-therapeutics-debuts-with-expert-leadership-high-impact-pipeline-and-50-million-of-committed-capital/>, <https://clinicaltrials.gov/study/NCT07504458> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/apl/> ;
  onco:sections <https://onco.cc/fronts/chemotherapy/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> .